Epigenetik Pada Sindrom Ovarium Polikistik: Gangguan Proses Folikulogenesis Yang Melibatkan Gen Reseptor Androgen, Reseptor Follicle-Stimulating Hormone Dan Reseptor Luteinizing Hormone
DOI:
https://doi.org/10.54957/ijhs.v4i1.683Kata Kunci:
Androgen, Folikulogenesis, FSH, LH, SOPKAbstrak
Sindrom Ovarium Polikistik (SOPK) merupakan salah satu gangguan hormonal yang dialami oleh wanita. Gangguan ini menyebabkan disregulasi proses neuroendokrin dan mengganggu proses pembentukan folikel (folikulogenesis). Etiologi gangguan folikulogenesis pada Sindrom Ovarium Polikistik disebabkan oleh reseptor androgen, reseptor follicle stimulating hormone (FSH), dan reseptor luteinizing hormone (LH). Beberapa pendekatan ilmiah digunakan untuk memahami penyebab gangguan folikulogenesis pada Sindrom Ovarium Polikistik, salah satunya epigenetik. Faktor epigenetik seperti metilasi DNA dan modifikasi histon diduga menjadi salah satu penyebab gangguan pengaturan sinyal luteinizing hormone dan follicle stimulating hormone pada folikulogenesis. Sinyal luteinizing hormone dan follicle-stimulating hormone diatur oleh reseptor luteinizing hormone dan reseptor follicle stimulating hormone yang memiliki ekspresi messenger RNA (mRNA) yang berbeda dibandingkan dengan kondisi normal. Reseptor luteinizing hormone diekspresikan secara berlebihan pada sel teka dan sel granulosa, sedangkan reseptor follicle stimulating hormone mengalami represi ekspresi gen pada sel granulosa. Hiperandrogenisme yang dimediasi reseptor androgen juga diatur secara berbeda pada Sindrom Ovarium Polikistik.
Referensi
Balen, A. (2004). The pathophysiology of polycystic ovary syndrome: Trying to understand PCOS and its endocrinology. In Best Practice and Research: Clinical Obstetrics and Gynaecology (Vol. 18, Issue 5 SPEC. ISS., pp. 685–706). Bailliere Tindall Ltd. https://doi.org/10.1016/j.bpobgyn.2004.05.004
Bradbury, R. A., Lee, P., & Smith, H. C. (2017). Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(5), 552–557. https://doi.org/10.1111/ajo.12647
Caglar, G. S., Kahyaoglu, I., Pabuccu, R., Demirtas, S., & Seker, R. (2013). Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. Archives of Gynecology and Obstetrics, 288(4), 905–910. https://doi.org/10.1007/s00404-013-2833-9
Clark, S. J., Statham, A., Stirzaker, C., Molloy, P. L., & Frommer, M. (2006). DNA methylation: Bisulphite modification and analysis. Nature Protocols, 1(5), 2353–2364. https://doi.org/10.1038/nprot.2006.324
Hickey, T. E. (n.d.). Androgen Receptor Mediated Activity In The Ovary: Implications For Polycystic Ovary Syndrome.
Kevenaar, M. E., Themmen, A. P. N., van Kerkwijk, A. J., Valkenburg, O., Uitterlinden, A. G., de Jong, F. H., Laven, J. S. E., & Visser, J. A. (2009). Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Human Reproduction, 24(1), 241–249. https://doi.org/10.1093/humrep/den353
Li, S., Zhu, D., Duan, H., & Tan, Q. (2016). The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations. In Gynecological Endocrinology (Vol. 32, Issue 12, pp. 942–946). Taylor and Francis Ltd. https://doi.org/10.1080/09513590.2016.1203409
Li, X., & Shao, R. (2014). Perspective PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. In Am J Cancer Res (Vol. 4, Issue 1). www.ajcr.us/ISSN:2156-6976/ajcr0000238
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25(2), 544–551. https://doi.org/10.1093/humrep/dep399
Nestler, J. E., & Jakubowicz, D. J. (1997). Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17 Activity and Serum Androgens*. In Journal of Clinical Endocrinology and Metabolism Printed (Vol. 82, Issue 12). https://academic.oup.com/jcem/article/82/12/4075/2865999
Qu, F., Wang, F. F., Yin, R., Ding, G. L., El-prince, M., Gao, Q., Shi, B. W., Pan, H. H., Huang, Y. T., Jin, M., Leung, P. K., Sheng, J. Z., & Huang, H. F. (2012). A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: Hyperandrogenism induces epigenetic alterations in the granulosa cells. Journal of Molecular Medicine, 90(8), 911–923. https://doi.org/10.1007/s00109-012-0881-4
Shen, H. ran, Qiu, L. hua, Zhang, Z. qing, Qin, Y. yuan, Cao, C., & Di, W. (2013). Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome. PLoS ONE, 8(5). https://doi.org/10.1371/journal.pone.0064801
Sirmans, S. M., & Pate, K. A. (2013). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology, 6(1), 1–13. https://doi.org/10.2147/clep.s37559
Wang, X.-X., Wei, J.-Z., Jiao, J., Jiang, S.-Y., Yu, D.-H., & Li, D. (2014). Oncotarget 6603 www.impactjournals.com/oncotarget Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. In Oncotarget (Vol. 5, Issue 16). www.impactjournals.com/oncotarget/
Xu, N., Azziz, R., & Goodarzi, M. O. (2010). Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertility and Sterility, 94(2). https://doi.org/10.1016/j.fertnstert.2009.10.020
Yildizhan, B., Anik Ilhan, G., & Pekin, T. (2016). The impact of insulin resistance on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology, 36(7), 893–896. https://doi.org/10.3109/01443615.2016.1168376
Yu, Y. Y., Sun, C. X., Liu, Y. K., Li, Y., Wang, L., & Zhang, W. (2015). Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome. Fertility and Sterility, 104(1), 145-153.e6. https://doi.org/10.1016/j.fertnstert.2015.04.005
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Steven Arianto, Afifa Radhina, Amalia Shari, Insani Fitrahulil Jannah, Mike Permata Sari
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
